This finding aligns with previous studies where genetic inactivation of ANGPTL4 was associated with improved insulin sensitivity and reduced risk of Type 2 diabetes (Gusarova et al., 2018). The gene discussed is ANGPTL4; the disease is type 2 diabetes mellitus.